Company Ovoca Bio plc Euronext Dublin

Equities

OVXA

IE0006649010

Biotechnology & Medical Research

End-of-day quote Euronext Dublin Other stock markets 2024-02-05			5-day change	1st Jan Change
0.0100 ^EUR	-.--%		-.--%	-

Feb. 24	Talisman Metals acquires two Morocco copper licences for GBP16,000	AN
Feb. 24	Talisman Metals Starts Exploration at Fougnar Copper-silver Project in Morocco	MT

Business description: Ovoca Bio plc

Ovoca Bio PLC is a clinical-stage biopharmaceutical company focused on womenâ€™s health. The Company is developing Orenetide, a novel medicinal treatment for premenopausal women with hypoactive sexual desire disorder (HSDD). It is focused on womenâ€™s health and identifying novel candidates in areas of high unmet medical need. The Companyâ€™s lead product, Orenetide (BP-101), is a novel synthetic peptide for the treatment of HSDD and is conveniently administered through a nasal spray. The spray delivers the drug to olfactory and trigeminal nerves in the nasal cavity where the drug accumulates in the olfactory bulb and further in the brain. It is also developing a new treatment for women affected by low libido or sex drive. It owns a patent portfolio that provides effective protection of its technology. The Company operates in Ireland, the United Kingdom and Russia.

Bio Therapeutic Drugs

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi.($)
ARGENX SE	-0.36%	-1.35%	+11.40%	+85.44%	42.98B
WUXI APPTEC CO., LTD.	-1.13%	-2.60%	+42.18%	+15.00%	39.24B
INSMED INCORPORATED	-0.01%	-0.45%	+82.23%	+661.46%	30.07B
BIONTECH SE	+1.21%	-10.16%	-8.32%	-30.06%	21.88B
WUXI BIOLOGICS (CAYMAN) INC.	-1.71%	-5.01%	+29.53%	-30.75%	18.25B
GENMAB A/S	-2.18%	-1.50%	+20.40%	-32.01%	16.03B
AKESO, INC.	-0.81%	+2.70%	+53.06%	+171.76%	12.97B
SUMMIT THERAPEUTICS INC.	+4.27%	+6.68%	-22.46%	+826.44%	12.5B
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+1.75%	+2.23%	+58.17%	-	11.76B
Average	+0.11%	-0.79%	+29.58%	+208.41%	22.85B
Weighted average by Cap.	-0.18%	-1.33%	+31.08%	+180.37%